Dr. Witta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3501 S Corona St
Ste 1
Englewood, CO 80113Phone+1 303-999-6745Fax+1 303-586-2228
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2001 - 2004
Northeastern Pennsylvania HospitalsResidency, Internal Medicine, 1998 - 2001
Karlovy University FOMClass of 1990
Certifications & Licensure
NE State Medical License 2024 - 2026
CO State Medical License 2001 - 2025
PA State Medical License 1999 - 2001- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC Start of enrollment: 2008 Jan 08
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- 1298 citationsEpidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerFederico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni Luca Ceresoli
Journal of the National Cancer Institute. 2005-05-04 - 144 citationsRandomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non–Small-Cell Lung Cancer Who Progressed on Prior ChemotherapySamir E. Witta, Robert M. Jotte, Katrik Konduri, Marcus A. Neubauer, Alexander I. Spira
Journal of Clinical Oncology. 2012-04-16 - 413 citationsRestoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.Samir E. Witta, Robert M. Gemmill, Fred R. Hirsch, Christopher D. Coldren, Karla J. Hedman
Cancer Research. 2006-01-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
